The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Shortly after a positive data drop for Eli Lilly’s efsitora a | Lilly revealed that its weekly insulin candidate efsitora ...

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

New research offers an alternative to daily insulin shots for the 8 million people in the United States with type 2 diabetes. Eli Lilly ... “This long-acting formulation could help address ...

Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...

Eli Lilly has released detailed results from the Phase III QWINT-2 and QWINT-5 trial showing that its once weekly insulin efsitora (efsitora alfa) demonstrated a similar reduction in HbA1C levels ...

To receive the full newsletter in your inbox for free sign up here, opens new tab) Eli Lilly’s ... trial also used a short-acting insulin at mealtimes. In July, Lilly rival Novo Nordisk ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical ...

A pair of late-stage trials found that Eli Lilly’s experimental once-weekly insulin can lower blood sugar as effectively as ...